Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
NEW ORLEANS, March 30, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 6, 2018 to file lead plaintiff applications in a securities class action lawsuit against MetLife, Inc. (NYSE:MET), if they purchased the Company’s securities between February 27, 2013 and January 29, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
MetLife investors should visit us at https://www.claimsfiler.com/cases/view-metlife-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
MetLife and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On January 29, 2018, MetLife disclosed “a material weakness in internal controls over financial reporting” that caused reserves to be reduced incorrectly relating to outstanding payouts for annuity and pension recipients and that its Q4 earnings release was postponed, with reserves expected to increase by $525 million to $575 million, Q4 earnings to decrease by $135 million to $165 million, and 2017 profits cut by $165 million to $195 million. MetLife also revealed a SEC investigation into the outstanding pension payments matter.
On this news, the price of MetLife’s shares plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
